Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Growth Rate of the Hematopoietic Stem Cell Transplantation Market?

The market size of hematopoietic stem cell transplantation has seen a robust increase in the recent past. The market, which stands at $4.68 billion in 2024, is predicted to rise to $5.12 billion in 2025, showing a compound annual growth rate (CAGR) of 9.3%. The historical growth can be accredited to early techniques of transplantation, limited indicators and sources of donors, progress in conditioning regimens, the introduction of allogeneic transplants, and significant regulatory milestones.

What Growth Rate Is Forecasted for the Hematopoietic Stem Cell Transplantation Market by 2029?

In the upcoming years, the market size for hematopoietic stem cell transplantation is forecasted to experience rapid expansion. The market is projected to reach a value of “$7.73 billion in 2029 with a compound annual growth rate (CAGR) of 10.9%. The expected growth in this period is credited to the expansion of treatment indications, diversification of donor sources, advancements in personalized medicine and genomics, regulatory alterations and guidelines, and increased market availability and access. Key trends within this forecast period encompass improvements in transplant techniques, expanding indications, the rise of cellular therapies, diversification of donors, and precision medicine approaches.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10445&type=smp

Which Key Companies Are Shaping the Future of the Hematopoietic Stem Cell Transplantation Market?

Major companies operating in the hematopoietic stem cell transplantation market include Pluristem Therapeutics Inc., Lonza Group AG, Escape Therapeutics Inc., Regen Biopharma Inc., Bluebird Bio Inc., CellGenix GmbH, CBR Systems Inc., Merck KGaA, Cord Blood Corporation, Kiadis Pharma NV, Marker Therapeutics Inc., Taiga Biotechnologies Inc., Takeda Pharmaceutical Company Limited, Talaris Therapeutics Inc., ViaCord LLC, ScienCell Research Laboratories Inc., BiolineRx, Stemcell Technologies Inc., ThermoGenesis Holdings Inc., MEDIPOST Co. Ltd., Anterogen. Co. Ltd., Pharmicell Inc., JCR Pharmaceuticals Co. Ltd., Holostem Terapie Avanzate Srl, Regrow Biosciences Pvt Ltd., Stempeutics Research Pvt Ltd.

Which Factors Are Driving Demand in the Hematopoietic Stem Cell Transplantation Industry?

As the prevalence of blood cancer rises, this is anticipated to fuel the expansion of the hematopoietic stem cell transplantation market. Blood cancers are expressed as malignancies that affect the growth and functionality of blood cells. The three key forms of blood cancer include leukemia, lymphoma, and myeloma. Hematopoietic stem cell transplantation, which is commonly utilized to treat blood cancer, functions to replace malignant-affected stem cells and bone marrow cells. These fresh stem cells then venture to the bone marrow, where they generate new blood cells. Accordingly, these aspects contribute to the propulsion of the hematopoietic stem cell transplantation market. For instance, as per the report released by Blood Cancer UK, a non-profit organization in the UK, in August 2022, each year identifies 41,000 blood cancer cases; thus, blood cancer is the sixth most common form of cancer in the UK. Affecting one in 16 men and one in 22 women in their lifetime, blood cancer is projected to impact around 250,000 people in the UK in 2022. Furthermore, each year, blood cancer is diagnosed in more than 500 children below the age of 15, with 400 cases of pediatric leukemia and 100 diagnosed with lymphoma. Accordingly, this rising trend of blood cancer contributes to the hematopoietic stem cell transplantation market’s expansion.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=10445&type=smp

How Is the Hematopoietic Stem Cell Transplantation Market Segmented by Several Divisions?

The hematopoietic stem cell transplantation market covered in this report is segmented –

1) By Type: Allogeneic, Autologous

2) By Indication: Leukemia, Lymphatic Disorder, Myeloma, Other Non-Malignant Disorders

3) By Application: Bone Marrow Transplant, Peripheral Blood Stem Cell Transplant, Cord Blood Transplant

4) By End User: Hospital Pharmacy, Retail Pharmacy, Specialty Clinics

Subsegments:

1) By Allogeneic: Matched Related Donor Transplantation, Matched Unrelated Donor Transplantation, Cord Blood Transplantation

2) By Autologous: Peripheral Blood Stem Cell Transplantation, Bone Marrow Stem Cell Transplantation

What are the Emerging Market Trends Driving the Growth of the Hematopoietic Stem Cell Transplantation Industry?

Gaining popularity in the hematopoietic stem cell transplantation market is the trend of product approvals. To maintain their market standing, leading companies in this sector are opting for product approvals. For example, in April 2022, Priothera Ltd., a biotechnology company in the late-clinical stage based in Ireland, was approved by the United States Food and Drug Administration (FDA) for a new investigational drug (IND) to initiate a Phase IIb/III trial of allogenic hematopoietic stem cell transplant (HSCT) using mocravimod with patients suffering from acute myeloid leukemia (AML). Mocravimod, also known as KRP203, is a modulator of the synthetic sphingosine 1-phosphate receptor (S1PR). This novel experimental medication’s safety, tolerability, and efficacy have been assessed in Phase I and Phase II trials for various autoimmune disorders.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/hematopoietic-stem-cell-transplantation-global-market-report

Which Regions Are Driving Growth in the Hematopoietic Stem Cell Transplantation Market?

North America was the largest region in the hematopoietic stem cell transplantation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global hematopoietic stem cell transplantation market during the forecast period. The regions covered in the hematopoietic stem cell transplantation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10445

This Report Delivers Insight On:

1. How big is the hematopoietic stem cell transplantation market, and how is it changing globally?

2. Who are the major companies in the hematopoietic stem cell transplantation market, and how are they performing?

3. What are the key opportunities and risks in the hematopoietic stem cell transplantation market right now?

4. Which products or customer segments are growing the most in the hematopoietic stem cell transplantation market?

5. What factors are helping or slowing down the growth of the hematopoietic stem cell transplantation market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model